-
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?
Shionogi, the Japanese company that makes Xocova (ensitrelvir), said the post-exposure prophylaxis drug will be available in mid-July in the U.S. and will have a list price of $1,400. But its impact will hinge on how easily people can access it, experts say. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSS
Policy & Advocacy
-
Long COVID is a smoldering threat to wildland firefighters
-
Immune system damage from COVID-19 is different from HIV/AIDS — but the advocacy has parallels
-
COVID-19 advocates are distributing masks to protect Californians from wildfire smoke
-
How America lost control of the bird flu, setting the stage for another pandemic
-
Dr. Gemma Carey, Australian public health scholar and Long COVID advocate, dies at 43
-
California Governor Gavin Newsom declares state of emergency for bird flu
Science
-
Nicotine patches help relieve symptoms in some people with Long COVID. Can the science behind it lead to future therapies?
-
Research updates, October 14
-
Getting diagnosed with hypermobility can help some people with Long COVID. Upcoming guidelines may make it easier.
-
Research updates, October 7
-
Research updates, September 30
-
Long COVID is not FND, but some patients are getting diagnosed with it. Here’s what to do if it happens to you.
Covid-19
-
National COVID-19 trends, July 8
-
National COVID-19 trends, July 1
-
National COVID-19 trends, June 24
-
The federal government is restricting COVID-19 vaccine access. Here’s what that means for the ongoing pandemic and people with Long COVID.
-
National COVID-19 trends, June 17
-
National COVID-19 trends, June 10
Health
-
Emergency departments aren’t trained for Long COVID — and patients are paying the price
-
COVID-19 triggered a life-threatening pulmonary embolism that led to long-term lung damage. It took two ER trips before doctors believed me.
-
This surgery fuses people’s skulls to their spines to treat a condition overlapping with myalgic encephalomyelitis
-
Letter to the editors: The University of Washington’s Long COVID clinic
-
$11 billion CDC funding cuts may decimate Long COVID response in several states
-
“It’s like torture”: The tilt table test could be risky for many people with Long COVID
-
Long COVID data are being erased, again
-
A serendipitous friendship taught me my greatest lesson in living with Long COVID: How to just be
-
The sick soft butch who did: How confronting a racist in my neighborhood helped me claim my Long COVID identity
-
Our community came together to start International Long COVID Awareness Day in 2023. Here’s how you can get involved this year.